Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Akero Therapeutics Inc (AKRO)

Akero Therapeutics Inc (AKRO)
39.91 +1.41 (+3.66%) 09:35 ET [NASDAQ]
39.79 x 13 40.00 x 34
Realtime by (Cboe BZX)
39.79 x 13 40.00 x 34
Realtime 39.51 +1.01 (+2.62%) 09:19 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
38.00
Day High
39.28
Open 38.03
Previous Close 37.67 37.67
Volume 946 946
Avg Vol 1,141,578 1,141,578
Stochastic %K 67.82% 67.82%
Weighted Alpha -1.92 -1.92
5-Day Change +1.32 (+3.47%) +1.32 (+3.47%)
52-Week Range 17.86 - 58.40 17.86 - 58.40
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,065,370
  • Shares Outstanding, K 79,620
  • Annual Sales, $ 0 K
  • Annual Income, $ -252,060 K
  • EBIT $ -285 M
  • EBITDA $ -298 M
  • 60-Month Beta -0.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.51

Options Overview Details

View History
  • Implied Volatility 64.09% ( +5.24%)
  • Historical Volatility 64.88%
  • IV Percentile 56%
  • IV Rank 14.03%
  • IV High 293.20% on 01/16/25
  • IV Low 26.69% on 08/16/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 2,230
  • Volume Avg (30-Day) 1,051
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 19,613
  • Open Int (30-Day) 24,976

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.00
  • Number of Estimates 4
  • High Estimate -0.94
  • Low Estimate -1.09
  • Prior Year -0.90
  • Growth Rate Est. (year over year) -11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.80 +23.90%
on 04/09/25
Period Open: 45.22
46.14 -14.61%
on 03/24/25
-5.82 (-12.87%)
since 03/21/25
3-Month
25.69 +53.37%
on 01/24/25
Period Open: 26.16
58.40 -32.53%
on 01/27/25
+13.24 (+50.61%)
since 01/23/25
52-Week
17.86 +120.60%
on 06/05/24
Period Open: 21.00
58.40 -32.53%
on 01/27/25
+18.40 (+87.62%)
since 04/23/24

Most Recent Stories

More News
3 Mid-Caps Worth Watching Closely in March 

Unlike their mega-cap counterparts, which tend to grind, mid-caps can soar or crash within days, driven by headlines and pure speculation.

AKRO : 39.90 (+3.64%)
HEES : 91.11 (+2.03%)
OKLO : 22.61 (+5.02%)
HRI : 112.15 (+9.59%)
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

AKRO : 39.90 (+3.64%)
This Stock Just Doubled in 1 Day -- Is It Still a Buy?

We are still pretty early in the new year, but some companies are already delivering outsize returns to their shareholders. Akero Therapeutics (NASDAQ: AKRO) is part of this group. On Jan. 27, the company's...

AKRO : 39.90 (+3.64%)
Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

AKRO : 39.90 (+3.64%)
Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

AKRO : 39.90 (+3.64%)
Technology Stocks Upended by China’s DeepSeek

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -1.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.97%. March E-mini...

MSTR : 350.54 (+2.19%)
JNJ : 156.06 (-1.07%)
KHC : 29.97 (-0.76%)
COIN : 197.11 (+3.74%)
AMD : 91.64 (+6.24%)
SPY : 540.74 (+2.56%)
PTLO : 11.27 (+3.97%)
HCA : 331.10 (+2.00%)
MU : 73.94 (+5.31%)
CAG : 25.30 (-0.71%)
AMT : 214.89 (-2.75%)
ORCL : 134.04 (+5.34%)
Akero Therapeutics Announces Proposed Public Offering of Common Stock

AKRO : 39.90 (+3.64%)
Stocks Hit by AI Jitters

The S&P 500 Index ($SPX ) (SPY ) today is down -1.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.68%. March E-mini S&P futures...

MSTR : 350.54 (+2.19%)
AMAT : 145.58 (+5.26%)
CVS : 65.21 (-0.37%)
AVGO : 178.04 (+4.99%)
KHC : 29.97 (-0.76%)
JNJ : 156.06 (-1.07%)
$IUXX : 18,276.41 (+2.63%)
COIN : 197.11 (+3.74%)
UNH : 424.86 (-0.54%)
ASML : 658.45 (+3.09%)
ZNM25 : 111-115 (+0.51%)
ESM25 : 5,453.00 (+2.60%)
Stocks Slump as China’s DeepSeek Rattles Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -1.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.66%. March E-mini S&P futures...

MSTR : 350.54 (+2.19%)
AMAT : 145.58 (+5.26%)
GOOGL : 155.92 (+2.94%)
AVGO : 178.04 (+4.99%)
KHC : 29.97 (-0.76%)
JNJ : 156.06 (-1.07%)
$IUXX : 18,276.41 (+2.63%)
COIN : 197.11 (+3.74%)
UNH : 424.86 (-0.54%)
ASML : 658.45 (+3.09%)
ZNM25 : 111-115 (+0.51%)
MSFT : 377.42 (+2.89%)
Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant

The analyst highlighted that major pharmaceutical companies are already pursuing GLP-1-based therapies for MASH, but he believes efruxifermin could complement these treatments.

IWN : 145.28 (+2.85%)
AKRO : 39.90 (+3.64%)
XBI : 80.02 (+3.07%)
Flora Launches Limited Edition Compass Rise Crimson, Perfectly Timed for the Holiday Season

Fort Lauderdale, Florida--(Newsfile Corp. - December 2, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is thrilled to announce the launch of the limited-edition Compass...

FLGC : 0.5200 (unch)
Flora Expands European Success with Thriving Partnership in Czech Republic and Slovakia

Fort Lauderdale, Florida--(Newsfile Corp. - November 26, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce it has renewed its sales orders for the...

FLGC : 0.5200 (unch)
Flora Unveils Element, Revolutionizing Glass Bubbler

Fort Lauderdale, Florida--(Newsfile Corp. - November 21, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of Element, the latest innovation...

FLGC : 0.5200 (unch)
Flora Growth Leads the Charge in Australia with Innovative Solutions for Pharmacies

Fort Lauderdale, Florida--(Newsfile Corp. - November 20, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is positioning itself as a first mover in response to Australia's...

FLGC : 0.5200 (unch)
Flora Growth Corp. Highlights President-Elect Trump's Historic Support for Hemp Industry Growth Following 2018 Farm Bill

Fort Lauderdale, Florida--(Newsfile Corp. - November 19, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") acknowledges the pivotal role that President-Elect Donald Trump...

FLGC : 0.5200 (unch)
Flora Growth Corp. Reports Third Quarter 2024 Financial Results

Fort Lauderdale, Florida--(Newsfile Corp. - November 13, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the three...

FLGC : 0.5200 (unch)
Flora Growth Corp. Congratulates President-Elect Donald Trump, Calls for Immediate Action on Cannabis Reform

Fort Lauderdale, Florida--(Newsfile Corp. - November 6, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") extends its congratulations to President-Elect Donald Trump on his...

FLGC : 0.5200 (unch)
Flora Growth Corp. Reaffirms Medical Cannabis Supply Agreement with Curaleaf

Fort Lauderdale, Florida--(Newsfile Corp. - November 4, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today reaffirms its medical cannabis supply agreement with Curaleaf...

FLGC : 0.5200 (unch)
Flora Growth Corp. Supports Germany's Cannabis Model City Initiative, Pioneering Controlled THC Retail in Frankfurt and Hannover

Fort Lauderdale, Florida--(Newsfile Corp. - October 31, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today announced its strong support for Germany's historic cannabis...

FLGC : 0.5200 (unch)
Flora Growth Corp. Targeting $4 Billion Market, Launching Parallel Import Business in Germany

Fort Lauderdale, Florida--(Newsfile Corp. - October 30, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of its parallel import business...

FLGC : 0.5200 (unch)
Flora Launches Limited Edition Compass Rise Crimson, Perfectly Timed for the Holiday Season

Fort Lauderdale, Florida--(Newsfile Corp. - December 2, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is thrilled to announce the launch of the limited-edition Compass...

FLGC : 0.5200 (unch)
Flora Expands European Success with Thriving Partnership in Czech Republic and Slovakia

Fort Lauderdale, Florida--(Newsfile Corp. - November 26, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce it has renewed its sales orders for the...

FLGC : 0.5200 (unch)
Flora Unveils Element, Revolutionizing Glass Bubbler

Fort Lauderdale, Florida--(Newsfile Corp. - November 21, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of Element, the latest innovation...

FLGC : 0.5200 (unch)
Flora Growth Leads the Charge in Australia with Innovative Solutions for Pharmacies

Fort Lauderdale, Florida--(Newsfile Corp. - November 20, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is positioning itself as a first mover in response to Australia's...

FLGC : 0.5200 (unch)
Flora Growth Corp. Highlights President-Elect Trump's Historic Support for Hemp Industry Growth Following 2018 Farm Bill

Fort Lauderdale, Florida--(Newsfile Corp. - November 19, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") acknowledges the pivotal role that President-Elect Donald Trump...

FLGC : 0.5200 (unch)
Flora Growth Corp. Reports Third Quarter 2024 Financial Results

Fort Lauderdale, Florida--(Newsfile Corp. - November 13, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the three...

FLGC : 0.5200 (unch)
Flora Growth Corp. Congratulates President-Elect Donald Trump, Calls for Immediate Action on Cannabis Reform

Fort Lauderdale, Florida--(Newsfile Corp. - November 6, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") extends its congratulations to President-Elect Donald Trump on his...

FLGC : 0.5200 (unch)
Flora Growth Corp. Reaffirms Medical Cannabis Supply Agreement with Curaleaf

Fort Lauderdale, Florida--(Newsfile Corp. - November 4, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today reaffirms its medical cannabis supply agreement with Curaleaf...

FLGC : 0.5200 (unch)
Flora Growth Corp. Supports Germany's Cannabis Model City Initiative, Pioneering Controlled THC Retail in Frankfurt and Hannover

Fort Lauderdale, Florida--(Newsfile Corp. - October 31, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today announced its strong support for Germany's historic cannabis...

FLGC : 0.5200 (unch)
Flora Growth Corp. Targeting $4 Billion Market, Launching Parallel Import Business in Germany

Fort Lauderdale, Florida--(Newsfile Corp. - October 30, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of its parallel import business...

FLGC : 0.5200 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company's product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which...

See More

Key Turning Points

3rd Resistance Point 40.47
2nd Resistance Point 39.87
1st Resistance Point 39.19
Last Price 39.90
1st Support Level 37.91
2nd Support Level 37.31
3rd Support Level 36.63

See More

52-Week High 58.40
Fibonacci 61.8% 42.91
Last Price 39.90
Fibonacci 50% 38.13
Fibonacci 38.2% 33.35
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.